Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.595 USD | +2.36% | +1.47% | -9.83% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.83% | 403M | |
+2.23% | 42.59B | |
+7.63% | 40.65B | |
+48.88% | 40.57B | |
-11.96% | 26.77B | |
+8.66% | 24.81B | |
-23.90% | 18.17B | |
+27.74% | 12.05B | |
-2.77% | 11.7B | |
+7.00% | 11.1B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Adjusts Voyager Therapeutics Price Target to $4 From $3, Maintains Neutral Rating